Perfil
Glenn A. Hopkins is currently a Director at RHEI Pharmaceuticals, Inc. Prior to his current position, he worked as a Principal at Thomas H.
Lee Partners LP from 1989 to 1994 and as a Partner at Prospect Hill Growth Partners LP from 1995 to 2014.
Hopkins received his undergraduate and graduate degrees from the Massachusetts Institute of Technology.
Cargos activos de Glenn A. Hopkins
| Empresas | Cargo | Inicio |
|---|---|---|
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acquires, licenses, develops and commercializes therapies | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Glenn A. Hopkins.
| Empresas | Cargo | Fin |
|---|---|---|
Thomas H. Lee Partners LP
Thomas H. Lee Partners LP Investment ManagersFinance Thomas H Lee Partners invests in middle market companies located in the United States. The firm targets companies operating in the fields of financial technology & services, healthcare, technology & business solutions and automation sectors. It provides financing for growth, acquisitions, recapitalizations and buyout stage capital transactions. | Corporate Officer/Principal | 31/12/1994 |
Prospect Hill Growth Partners LP
Prospect Hill Growth Partners LP Investment ManagersFinance Prospect Hill Growth Partners invests in middle-market growth companies located in North America with revenues of USD 50 - 300 million and EBITDA of USD 5 - 25 million. The firm focuses on the consumer and healthcare strategy sectors. It participates in buyout transactions with an investment size of USD 25 - 100 million. It also makes co-investments. | Corporate Officer/Principal | - |
Formación de Glenn A. Hopkins.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Thomas H. Lee Partners LP
Thomas H. Lee Partners LP Investment ManagersFinance Thomas H Lee Partners invests in middle market companies located in the United States. The firm targets companies operating in the fields of financial technology & services, healthcare, technology & business solutions and automation sectors. It provides financing for growth, acquisitions, recapitalizations and buyout stage capital transactions. | Finance |
Prospect Hill Growth Partners LP
Prospect Hill Growth Partners LP Investment ManagersFinance Prospect Hill Growth Partners invests in middle-market growth companies located in North America with revenues of USD 50 - 300 million and EBITDA of USD 5 - 25 million. The firm focuses on the consumer and healthcare strategy sectors. It participates in buyout transactions with an investment size of USD 25 - 100 million. It also makes co-investments. | Finance |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acquires, licenses, develops and commercializes therapies | Health Technology |
- Bolsa de valores
- Insiders
- Glenn A. Hopkins
















